ClearPoint Neuro CLPT recently announced the full market release of its SmartFrame OR platform and ClearPoint Prism Neuro Laser Therapy System. The newly launched technologies are likely to be on ...
ClearPoint Neuro's stock has performed well over the past 4 months, supported by solid business fundamentals. Despite the move higher, ClearPoint's valuation is still modest, given the company's ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
ClearPoint Neuro (NASDAQ:CLPT) said it has received FDA clearance for its SmartFrame OR Stereotactic System for neurological procedures. The company plans to conduct a limited release of the product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback